2006 annual financial data
Halozyme Therapeutics 2006 Operating cash flow growth
Direct answer
Operating cash flow growth was Not calculable.
Operating income was -15,582,856 USD and net income was -14,751,986 USD.
Operating cash flow was 7,079,563 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 981,746 USD
- Operating income
- -15,582,856 USD
- Net income
- -14,751,986 USD
- Operating cash flow
- 7,079,563 USD